Atai Life Sciences Operating Margin 2020-2024 | ATAI
Current and historical operating margin for Atai Life Sciences (ATAI) over the last 10 years. The current operating profit margin for Atai Life Sciences as of September 30, 2024 is 0.00%.
| Atai Life Sciences Operating Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Operating Income | Operating Margin |
| 2024-09-30 | $0.00B | $-0.11B | inf% |
| 2024-06-30 | $0.00B | $-0.11B | inf% |
| 2023-12-31 | $0.00B | $-0.13B | inf% |
| 2023-09-30 | $0.00B | $-0.13B | inf% |
| 2023-06-30 | $0.00B | $-0.14B | inf% |
| 2023-03-31 | $0.00B | $-0.14B | inf% |
| 2022-09-30 | $0.00B | $-0.15B | inf% |
| 2022-06-30 | $0.00B | $-0.15B | inf% |
| 2021-12-31 | $0.02B | $-0.14B | -675.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $0.200B | $0.000B |
| atai Life Sciences B.V. is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. atai Life Sciences B.V. is based in BERLIN. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $19.704B | 11.92 |
| Quest Diagnostics (DGX) | United States | $16.912B | 17.14 |
| DaVita (DVA) | United States | $12.098B | 15.65 |
| Encompass Health (EHC) | United States | $9.453B | 22.29 |
| Chemed (CHE) | United States | $7.853B | 24.14 |
| Elanco Animal Health (ELAN) | United States | $5.843B | 13.91 |
| RadNet (RDNT) | United States | $5.284B | 117.02 |
| Option Care Health (OPCH) | United States | $3.848B | 18.23 |
| Amedisys (AMED) | United States | $2.744B | 19.53 |
| LifeStance Health (LFST) | United States | $2.698B | 0.00 |
| Addus HomeCare (ADUS) | United States | $2.350B | 27.57 |
| Astrana Health (ASTH) | United States | $1.974B | 26.99 |
| U.S Physical Therapy (USPH) | United States | $1.380B | 36.27 |
| Pennant (PNTG) | United States | $0.938B | 37.92 |
| Aveanna Healthcare Holdings (AVAH) | United States | $0.873B | 0.00 |
| Bioqual (BIOQ) | United States | $0.059B | 0.00 |
| Daxor (DXR) | United States | $0.039B | 0.00 |
| Ontrak (OTRK) | United States | $0.006B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.005B | 0.00 |
| IMAC Holdings (BACK) | United States | $0.001B | 0.00 |
| Psychemedics (PMD) | United States | $0.000B | 0.00 |